Yatharth Hospit.

Q1 FY27Healthcare Services

Yatharth Hospit. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹925

Market cap₹8.2K Cr

P/E45.5

Updated25 Aug 2026

Read4 min read

The short version

FY27 revenue growth is expected to surpass last year's 37% YoY growth. Revenue growth for FY27 is expected to surpass last year's 37% Y-o-Y growth, with sustained momentum ahead.

From Yatharth Hospit.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

FY27 revenue growth is expected to surpass last year's 37% YoY growth.
ARPOB (Average Revenue Per Occupied Bed) growth guidance for FY27 is around 9-10% YoY.
Newer hospitals have ARPOB around INR 40,000-50,000, expected to grow 8-10% annually.
EBITDA margin expected upwards of 24% for FY27, with new hospitals projected to reach 25-27% EBITDA margins within 2 years.
Capacity expansion targets 3,200 beds operational soon, with a goal to reach 5,000 beds within approximately 2.5 years, faster than the originally planned 3 years.
Growth focus remains on North India clusters (Delhi NCR, UP, Haryana, Rajasthan) with potential new metro clusters.
Expansion includes greenfield, brownfield, and acquisitions, aiming to add at least one new hospital per year.
Overall growth momentum expected to be sustained in coming years.

Profitability & Margins

Revenue growth for FY27 is expected to surpass last year's 37% Y-o-Y growth, with sustained momentum ahead.
EBITDA margin guidance for FY27 is around 24% to 25%, with expectations of maintaining or slightly improving this level in coming years.
Newer hospitals currently around breakeven are targeted to achieve EBITDA margins of 25-27% within two years.
ARPOB (Average Revenue Per Occupied Bed) is projected to grow at 8-10% annually over the next 2-3 years, with newer hospitals already clocking INR 40,000-50,000 ARPOB.
PAT margins have seen short-term pressure due to high capex and interest costs but expected to stabilize and improve as new assets mature and capex normalizes.
Management confident of achieving target bed capacity of 5,000 beds earlier than planned, supporting higher scale and earnings growth.
Debt levels are manageable with sufficient internal accruals to fund expansions, supporting sustainable profit growth.

See what Yatharth Hospit. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex per bed is expected to be around INR 75-80 lakhs, including greenfield, brownfield, and acquisitions.
The Gurugram facility construction is progressing and expected to go live by Q1 of the next fiscal year.
Brownfield expansions planned at Noida Extension and Greater Noida, with capacity additions expected in 15-18 months.
Total bed capacity to reach over 3,200 beds soon, aiming for 5,000 beds within the next 2.5-3 years, possibly earlier.
No significant fresh loans planned; capex funded through internal accruals and existing debt (currently around INR 300 crores).
Focus on acquisitions of premium assets with high ARPOB potential in cities where they operate.
Oncology equipment investments made recently for Faridabad and Model Town hospitals, contributing to capex.
ESOP schemes introduced to retain talent, supporting strategic human capital investment.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹981 Cr

Rev 1Mar 1

2CHANDAN₹518 Cr

Rev 1Mar 3

3₹66.5K Cr

Rev 2Mar 1

4₹654 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company currently has a debt of around INR 300 crores, increased from INR 210 crores mainly due to INR 80 crores taken for acquisitions.
Going forward, they plan to utilize internal accruals to fund acquisitions and maintenance/growth capex in existing hospitals.
They do not intend to take fresh loans in the near term, so interest costs are expected to remain stable (Q1 interest cost INR 6.6 crores).
Management is comfortable with current debt levels, having capacity to take up to 2x trailing EBITDA at the group level.
No explicit mention of upcoming equity fundraising; focus is on using internal accruals and manageable debt.
The company is well-positioned with cash, debt capacity, and accruals to fund the remaining capex for adding 1,800 beds.

See what Yatharth Hospit. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention current or expected orderbook or pending orders for Yatharth Hospitals and Trauma Care Services Limited. However, key related points include: - The company is actively progressing on brownfield expansions at Noida Extension and Greater Noida, expecting 450 additional beds operational in about 15-18 months. - The Gurugram facility with 250 beds is expected to be live by Q1 of the next financial year (FY28). - The roadmap targets doubling capacity from current 3,200 beds to 5,000 beds, likely earlier than 3 years, primarily within North India clusters. - Significant capex including acquisition of Gurgaon and oncology equipment indicates ongoing investment commitments. - Discussions mention no fresh loans planned for the near term, indicating order execution is ongoing based on existing financing. No direct reference to orderbooks or pending order values was provided in the transcript.

Yatharth Hospit. — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹342 Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Yatharth Hospital & Trauma Care Services Ltd's management said in earlier quarters

Others in Healthcare Services this season

Manipal Health Enterprises Ltd (Q1 FY27)
Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…
Fortis Healthcare Ltd (Q1 FY27)
IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…
Metropolis Healthcare Ltd (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
Apollo Hospitals Enterprise Ltd (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare Institute Ltd vs Manipal Health Enterprises Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Yatharth Hospit. Q1 FY27 results?

FY27 revenue growth is expected to surpass last year's 37% YoY growth. Revenue growth for FY27 is expected to surpass last year's 37% Y-o-Y growth, with sustained momentum ahead.

What is Yatharth Hospit. share price analysis?

Yatharth Hospit. currently shows a neutral. The stock trades at a P/E of 45.5 with a market cap of ₹8,240 Cr. Investors should review the full earnings analysis for detailed insights.

Is Yatharth Hospit. planning capital expenditure?

Capex per bed is expected to be around INR 75-80 lakhs, including greenfield, brownfield, and acquisitions.

Keep Yatharth Hospit. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.